Global Recombinant Human Endostatin Market Research Report Forecast 2017-2021

May 2017 | 108 pages | ID: G2688264357EN
S&P Consulting

Abstracts

The Global Recombinant Human Endostatin Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the Recombinant Human Endostatin industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Recombinant Human Endostatin market study provides comprehensive data which enhances the understanding, scope and application of this report.

This report provides comprehensive analysis of

• Key market segments and sub-segments
• Evolving market trends and dynamics
• Changing supply and demand scenarios
• Quantifying market opportunities through market sizing and market forecasting
• Tracking current trends/opportunities/challenges
• Competitive insights
• Opportunity mapping in terms of technological breakthroughs

Global Recombinant Human Endostatin Market: Regional Segment Analysis

North America
Europe
China
Japan
Southeast Asia
India

The Major players reported in the market include:

Pfizer
Biocon
Mabtech
Novartis
Fujifilm Kyowa Kirin Biologics
Enzon Pharmaceuticals
Genexine
Hetero Drugs
Onyx Pharmaceuticals

Global Recombinant Human Endostatin Market: Product Segment Analysis

• Type 1
• Type 2
• Type 3

Global Recombinant Human Endostatin Market: Application Segment Analysis

• Application 1
• Application 2
• Application 3

Reasons for Buying this Report

• This report provides pin-point analysis for changing competitive dynamics
• It provides a forward looking perspective on different factors driving or restraining market growth
• It provides a six-year forecast assessed on the basis of how the market is predicted to grow
• It helps in understanding the key product segments and their future
• It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
• It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

Contents

CHAPTER 1 RECOMBINANT HUMAN ENDOSTATIN MARKET OVERVIEW

1.1 Product Overview and Scope of Recombinant Human Endostatin
1.2 Recombinant Human Endostatin Market Segmentation by Type
  1.2.1 Global Production Market Share of Recombinant Human Endostatin by Type in 2015
  1.2.1 Type
  1.2.2 Type
  1.2.3 Type
1.3 Recombinant Human Endostatin Market Segmentation by Application
  1.3.1 Recombinant Human Endostatin Consumption Market Share by Application in 2015
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 Recombinant Human Endostatin Market Segmentation by Regions
  1.4.1 North America
  1.4.2 China
  1.4.3 Europe
  1.4.4 Southeast Asia
  1.4.5 Japan
  1.4.6 India
1.5 Global Market Size (Value) of Recombinant Human Endostatin (2012-2021)

CHAPTER 2 GLOBAL ECONOMIC IMPACT ON RECOMBINANT HUMAN ENDOSTATIN INDUSTRY

2.1 Global Macroeconomic Environment Analysis
  2.1.1 Global Macroeconomic Analysis
  2.1.2 Global Macroeconomic Environment Development Trend
2.2 Global Macroeconomic Environment Analysis by Regions

CHAPTER 3 GLOBAL RECOMBINANT HUMAN ENDOSTATIN MARKET COMPETITION BY MANUFACTURERS

3.1 Global Recombinant Human Endostatin Production and Share by Manufacturers (2015 and 2016)
3.2 Global Recombinant Human Endostatin Revenue and Share by Manufacturers (2015 and 2016)
3.3 Global Recombinant Human Endostatin Average Price by Manufacturers (2015 and 2016)
3.4 Manufacturers Recombinant Human Endostatin Manufacturing Base Distribution, Production Area and Product Type
3.5 Recombinant Human Endostatin Market Competitive Situation and Trends
  3.5.1 Recombinant Human Endostatin Market Concentration Rate
  3.5.2 Recombinant Human Endostatin Market Share of Top 3 and Top 5 Manufacturers
  3.5.3 Mergers & Acquisitions, Expansion

CHAPTER 4 GLOBAL RECOMBINANT HUMAN ENDOSTATIN PRODUCTION, REVENUE (VALUE) BY REGION (2012-2017)

4.1 Global Recombinant Human Endostatin Production by Region (2012-2017)
4.2 Global Recombinant Human Endostatin Production Market Share by Region (2012-2017)
4.3 Global Recombinant Human Endostatin Revenue (Value) and Market Share by Region (2012-2017)
4.4 Global Recombinant Human Endostatin Production, Revenue, Price and Gross Margin (2012-2017)
4.5 North America Recombinant Human Endostatin Production, Revenue, Price and Gross Margin (2012-2017)
4.6 Europe Recombinant Human Endostatin Production, Revenue, Price and Gross Margin (2012-2017)
4.7 China Recombinant Human Endostatin Production, Revenue, Price and Gross Margin (2012-2017)
4.8 Japan Recombinant Human Endostatin Production, Revenue, Price and Gross Margin (2012-2017)
4.9 Southeast Asia Recombinant Human Endostatin Production, Revenue, Price and Gross Margin (2012-2017)
4.10 India Recombinant Human Endostatin Production, Revenue, Price and Gross Margin (2012-2017)

CHAPTER 5 GLOBAL RECOMBINANT HUMAN ENDOSTATIN SUPPLY (PRODUCTION), CONSUMPTION, EXPORT, IMPORT BY REGIONS (2012-2017)

5.1 Global Recombinant Human Endostatin Consumption by Regions (2012-2017)
5.2 North America Recombinant Human Endostatin Production, Consumption, Export, Import by Regions (2012-2017)
5.3 Europe Recombinant Human Endostatin Production, Consumption, Export, Import by Regions (2012-2017)
5.4 China Recombinant Human Endostatin Production, Consumption, Export, Import by Regions (2012-2017)
5.5 Japan Recombinant Human Endostatin Production, Consumption, Export, Import by Regions (2012-2017)
5.6 Southeast Asia Recombinant Human Endostatin Production, Consumption, Export, Import by Regions (2012-2017)
5.7 India Recombinant Human Endostatin Production, Consumption, Export, Import by Regions (2012-2017)

CHAPTER 6 GLOBAL RECOMBINANT HUMAN ENDOSTATIN PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

6.1 Global Recombinant Human Endostatin Production and Market Share by Type (2012-2017)
6.2 Global Recombinant Human Endostatin Revenue and Market Share by Type (2012-2017)
6.3 Global Recombinant Human Endostatin Price by Type (2012-2017)
6.4 Global Recombinant Human Endostatin Production Growth by Type (2012-2017)

CHAPTER 7 GLOBAL RECOMBINANT HUMAN ENDOSTATIN MARKET ANALYSIS BY APPLICATION

7.1 Global Recombinant Human Endostatin Consumption and Market Share by Application (2012-2017)
7.2 Global Recombinant Human Endostatin Consumption Growth Rate by Application (2012-2017)
7.3 Market Drivers and Opportunities
  7.3.1 Potential Applications
  7.3.2 Emerging Markets/Countries

CHAPTER 8 GLOBAL RECOMBINANT HUMAN ENDOSTATIN MANUFACTURERS ANALYSIS

8.1 Pfizer
  8.1.1 Company Basic Information, Manufacturing Base and Competitors
  8.1.2 Product Type, Application and Specification
  8.1.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.1.4 Business Overview
8.2 Biocon
  8.2.1 Company Basic Information, Manufacturing Base and Competitors
  8.2.2 Product Type, Application and Specification
  8.2.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.2.4 Business Overview
8.3 Mabtech
  8.3.1 Company Basic Information, Manufacturing Base and Competitors
  8.3.2 Product Type, Application and Specification
  8.3.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.3.4 Business Overview
8.4 Novartis
  8.4.1 Company Basic Information, Manufacturing Base and Competitors
  8.4.2 Product Type, Application and Specification
  8.4.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.4.4 Business Overview
8.5 Fujifilm Kyowa Kirin Biologics
  8.5.1 Company Basic Information, Manufacturing Base and Competitors
  8.5.2 Product Type, Application and Specification
  8.5.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.5.4 Business Overview
8.6 Enzon Pharmaceuticals
  8.6.1 Company Basic Information, Manufacturing Base and Competitors
  8.6.2 Product Type, Application and Specification
  8.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.6.4 Business Overview
8.7 Genexine
  8.7.1 Company Basic Information, Manufacturing Base and Competitors
  8.7.2 Product Type, Application and Specification
  8.7.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.7.4 Business Overview
8.8 Hetero Drugs
  8.8.1 Company Basic Information, Manufacturing Base and Competitors
  8.8.2 Product Type, Application and Specification
  8.8.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.8.4 Business Overview
8.9 Onyx Pharmaceuticals
  8.9.1 Company Basic Information, Manufacturing Base and Competitors
  8.9.2 Product Type, Application and Specification
  8.9.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.9.4 Business Overview

CHAPTER 9 RECOMBINANT HUMAN ENDOSTATIN MANUFACTURING COST ANALYSIS

9.1 Recombinant Human Endostatin Key Raw Materials Analysis
  9.1.1 Key Raw Materials
  9.1.2 Price Trend of Key Raw Materials
  9.1.3 Key Suppliers of Raw Materials
  9.1.4 Market Concentration Rate of Raw Materials
9.2 Proportion of Manufacturing Cost Structure
  9.2.1 Raw Materials
  9.2.2 Labor Cost
  9.2.3 Manufacturing Expenses
9.3 Manufacturing Process Analysis of Recombinant Human Endostatin

CHAPTER 10 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

10.1 Recombinant Human Endostatin Industrial Chain Analysis
10.2 Upstream Raw Materials Sourcing
10.3 Raw Materials Sources of Recombinant Human Endostatin Major Manufacturers in 2015
10.4 Downstream Buyers

CHAPTER 11 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

11.1 Marketing Channel
  11.1.1 Direct Marketing
  11.1.2 Indirect Marketing
  11.1.3 Marketing Channel Development Trend
11.2 Market Positioning
  11.2.1 Pricing Strategy
  11.2.2 Brand Strategy
  11.2.3 Target Client
11.3 Distributors/Traders List

CHAPTER 12 MARKET EFFECT FACTORS ANALYSIS

12.1 Technology Progress/Risk
  12.1.1 Substitutes Threat
  12.1.2 Technology Progress in Related Industry
12.2 Consumer Needs/Customer Preference Change
12.3 Economic/Political Environmental Change

CHAPTER 13 GLOBAL RECOMBINANT HUMAN ENDOSTATIN MARKET FORECAST (2017-2021)

13.1 Global Recombinant Human Endostatin Production, Revenue Forecast (2017-2021)
13.2 Global Recombinant Human Endostatin Production, Consumption Forecast by Regions (2017-2021)
13.3 Global Recombinant Human Endostatin Production Forecast by Type (2017-2021)
13.4 Global Recombinant Human Endostatin Consumption Forecast by Application (2017-2021)
13.5 Recombinant Human Endostatin Price Forecast (2017-2021)

CHAPTER 14 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Recombinant Human Endostatin
Figure Global Production Market Share of Recombinant Human Endostatin by Type in 2015
Figure Product Picture of Type I
Table Major Manufacturers of Type I
Figure Product Picture of Type II
Table Major Manufacturers of Type II
Figure Product Picture of Type III
Table Major Manufacturers of Type III
Table Recombinant Human Endostatin Consumption Market Share by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure Application 3 Examples
Figure North America Recombinant Human Endostatin Revenue (Million USD) and Growth Rate (2012-2021)
Figure Europe Recombinant Human Endostatin Revenue (Million USD) and Growth Rate (2012-2021)
Figure China Recombinant Human Endostatin Revenue (Million USD) and Growth Rate (2012-2021)
Figure Japan Recombinant Human Endostatin Revenue (Million USD) and Growth Rate (2012-2021)
Figure Southeast Asia Recombinant Human Endostatin Revenue (Million USD) and Growth Rate (2012-2021)
Figure India Recombinant Human Endostatin Revenue (Million USD) and Growth Rate (2012-2021)
Figure Global Recombinant Human Endostatin Revenue (Million UDS) and Growth Rate (2012-2021)
Table Global Recombinant Human Endostatin Capacity of Key Manufacturers (2015 and 2016)
Table Global Recombinant Human Endostatin Capacity Market Share by Manufacturers (2015 and 2016)
Figure Global Recombinant Human Endostatin Capacity of Key Manufacturers in 2015
Figure Global Recombinant Human Endostatin Capacity of Key Manufacturers in 2016
Table Global Recombinant Human Endostatin Production of Key Manufacturers (2015 and 2016)
Table Global Recombinant Human Endostatin Production Share by Manufacturers (2015 and 2016)
Figure 2015 Recombinant Human Endostatin Production Share by Manufacturers
Figure 2016 Recombinant Human Endostatin Production Share by Manufacturers
Table Global Recombinant Human Endostatin Revenue (Million USD) by Manufacturers (2015 and 2016)
Table Global Recombinant Human Endostatin Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Global Recombinant Human Endostatin Revenue Share by Manufacturers
Table 2016 Global Recombinant Human Endostatin Revenue Share by Manufacturers
Table Global Market Recombinant Human Endostatin Average Price of Key Manufacturers (2015 and 2016)
Figure Global Market Recombinant Human Endostatin Average Price of Key Manufacturers in 2015
Table Manufacturers Recombinant Human Endostatin Manufacturing Base Distribution and Sales Area
Table Manufacturers Recombinant Human Endostatin Product Type
Figure Recombinant Human Endostatin Market Share of Top 3 Manufacturers
Figure Recombinant Human Endostatin Market Share of Top 5 Manufacturers
Table Global Recombinant Human Endostatin Capacity by Regions (2012-2017)
Figure Global Recombinant Human Endostatin Capacity Market Share by Regions (2012-2017)
Figure Global Recombinant Human Endostatin Capacity Market Share by Regions (2012-2017)
Figure 2015 Global Recombinant Human Endostatin Capacity Market Share by Regions
Table Global Recombinant Human Endostatin Production by Regions (2012-2017)
Figure Global Recombinant Human Endostatin Production and Market Share by Regions (2012-2017)
Figure Global Recombinant Human Endostatin Production Market Share by Regions (2012-2017)
Figure 2015 Global Recombinant Human Endostatin Production Market Share by Regions
Table Global Recombinant Human Endostatin Revenue by Regions (2012-2017)
Table Global Recombinant Human Endostatin Revenue Market Share by Regions (2012-2017)
Table 2015 Global Recombinant Human Endostatin Revenue Market Share by Regions
Table Global Recombinant Human Endostatin Production, Revenue, Price and Gross Margin (2012-2017)
Table North America Recombinant Human Endostatin Production, Revenue, Price and Gross Margin (2012-2017)
Table Europe Recombinant Human Endostatin Production, Revenue, Price and Gross Margin (2012-2017)
Table China Recombinant Human Endostatin Production, Revenue, Price and Gross Margin (2012-2017)
Table Japan Recombinant Human Endostatin Production, Revenue, Price and Gross Margin (2012-2017)
Table Southeast Asia Recombinant Human Endostatin Production, Revenue, Price and Gross Margin (2012-2017)
Table India Recombinant Human Endostatin Production, Revenue, Price and Gross Margin (2012-2017)
Table Global Recombinant Human Endostatin Consumption Market by Regions (2012-2017)
Table Global Recombinant Human Endostatin Consumption Market Share by Regions (2012-2017)
Figure Global Recombinant Human Endostatin Consumption Market Share by Regions (2012-2017)
Figure 2015 Global Recombinant Human Endostatin Consumption Market Share by Regions
Table North America Recombinant Human Endostatin Production, Consumption, Import & Export (2012-2017)
Table Europe Recombinant Human Endostatin Production, Consumption, Import & Export (2012-2017)
Table China Recombinant Human Endostatin Production, Consumption, Import & Export (2012-2017)
Table Japan Recombinant Human Endostatin Production, Consumption, Import & Export (2012-2017)
Table Southeast Asia Recombinant Human Endostatin Production, Consumption, Import & Export (2012-2017)
Table India Recombinant Human Endostatin Production, Consumption, Import & Export (2012-2017)
Table Global Recombinant Human Endostatin Production by Type (2012-2017)
Table Global Recombinant Human Endostatin Production Share by Type (2012-2017)
Figure Production Market Share of Recombinant Human Endostatin by Type (2012-2017)
Figure 2015 Production Market Share of Recombinant Human Endostatin by Type
Table Global Recombinant Human Endostatin Revenue by Type (2012-2017)
Table Global Recombinant Human Endostatin Revenue Share by Type (2012-2017)
Figure Production Revenue Share of Recombinant Human Endostatin by Type (2012-2017)
Figure 2015 Revenue Market Share of Recombinant Human Endostatin by Type
Table Global Recombinant Human Endostatin Price by Type (2012-2017)
Figure Global Recombinant Human Endostatin Production Growth by Type (2012-2017)
Table Global Recombinant Human Endostatin Consumption by Application (2012-2017)
Table Global Recombinant Human Endostatin Consumption Market Share by Application (2012-2017)
Figure Global Recombinant Human Endostatin Consumption Market Share by Application in 2015
Table Global Recombinant Human Endostatin Consumption Growth Rate by Application (2012-2017)
Figure Global Recombinant Human Endostatin Consumption Growth Rate by Application (2012-2017)
Table Pfizer Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Pfizer Recombinant Human Endostatin Production, Revenue, Price and Gross Margin (2012-2017)
Table Pfizer Recombinant Human Endostatin Market Share (2012-2017)
Table Biocon Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Biocon Recombinant Human Endostatin Production, Revenue, Price and Gross Margin (2012-2017)
Table Biocon Recombinant Human Endostatin Market Share (2012-2017)
Table Mabtech Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Mabtech Recombinant Human Endostatin Production, Revenue, Price and Gross Margin (2012-2017)
Table Mabtech Recombinant Human Endostatin Market Share (2012-2017)
Table Novartis Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Novartis Recombinant Human Endostatin Production, Revenue, Price and Gross Margin (2012-2017)
Table Novartis Recombinant Human Endostatin Market Share (2012-2017)
Table Fujifilm Kyowa Kirin Biologics Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Fujifilm Kyowa Kirin Biologics Recombinant Human Endostatin Production, Revenue, Price and Gross Margin (2012-2017)
Table Fujifilm Kyowa Kirin Biologics Recombinant Human Endostatin Market Share (2012-2017)
Table Enzon Pharmaceuticals Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Enzon Pharmaceuticals Recombinant Human Endostatin Production, Revenue, Price and Gross Margin (2012-2017)
Table Enzon Pharmaceuticals Recombinant Human Endostatin Market Share (2012-2017)
Table Genexine Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Genexine Recombinant Human Endostatin Production, Revenue, Price and Gross Margin (2012-2017)
Table Genexine Recombinant Human Endostatin Market Share (2012-2017)
Table Hetero Drugs Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Hetero Drugs Recombinant Human Endostatin Production, Revenue, Price and Gross Margin (2012-2017)
Table Hetero Drugs Recombinant Human Endostatin Market Share (2012-2017)
Table Onyx Pharmaceuticals Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Onyx Pharmaceuticals Recombinant Human Endostatin Production, Revenue, Price and Gross Margin (2012-2017)
Table Onyx Pharmaceuticals Recombinant Human Endostatin Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Recombinant Human Endostatin
Figure Manufacturing Process Analysis of Recombinant Human Endostatin
Figure Recombinant Human Endostatin Industrial Chain Analysis
Table Raw Materials Sources of Recombinant Human Endostatin Major Manufacturers in 2015
Table Major Buyers of Recombinant Human Endostatin
Table Distributors/Traders List
Figure Global Recombinant Human Endostatin Production and Growth Rate Forecast (2017-2021)
Figure Global Recombinant Human Endostatin Revenue and Growth Rate Forecast (2017-2021)
Table Global Recombinant Human Endostatin Production Forecast by Regions (2017-2021)
Table Global Recombinant Human Endostatin Consumption Forecast by Regions (2017-2021)
Table Global Recombinant Human Endostatin Production Forecast by Type (2017-2021)
Table Global Recombinant Human Endostatin Consumption Forecast by Application (2017-2021)